Cyfuse Biomedical KK (TSE:4892) Market Cap : 円5,578.32 Mil (As of May. 03, 2024)

Cyfuse Biomedical KK Market Cap Chart

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial				10,113.06	9,535.63	9,400.00	6,722.88	6,015.46

Competitive Comparison of Cyfuse Biomedical KK's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyfuse Biomedical KK's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's Market Cap distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's Market Cap falls into.

Cyfuse Biomedical KK Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cyfuse Biomedical KK's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Cyfuse Biomedical KK's Market Cap for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK  (TSE:4892) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Cyfuse Biomedical KK Market Cap Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK (TSE:4892) Business Description